Dopamine AntagonistsDopamineDomperidonePsychotic DisordersMetoclopramideReceptors, Dopamine D2HaloperidolFlupenthixolSpiperoneReceptors, DopamineDopamine AgonistsPimozideReceptors, Dopamine D1TrifluperidolSulpirideBenzazepinesButaclamolFluphenazineButyrophenonesErgotismTiapamil HydrochlorideBromocriptineReceptors, Dopamine D3Affective Disorders, PsychoticAntipsychotic AgentsErgolinesAcremoniumDopamine Plasma Membrane Transport ProteinsPsychoses, Substance-InducedProlactinDopamine AgentsDelusionsSchizophreniaDose-Response Relationship, DrugRats, Sprague-DawleyHallucinationsReceptors, Dopamine D5Behavior, AnimalDopamine Uptake InhibitorsDopamine beta-HydroxylaseCorpus StriatumSchizophrenic PsychologyRats, Inbred StrainsQuinpiroleSchizophrenia, ParanoidParanoid DisordersRacloprideExcitatory Amino Acid AntagonistsHormone AntagonistsNucleus AccumbensBipolar DisorderPsychiatric Status Rating ScalesSalicylamidesNarcotic AntagonistsApomorphineCocaineNeurokinin-1 Receptor AntagonistsAmphetamineNeostriatumHomovanillic AcidHistamine H2 AntagonistsBrainLevodopaMuscarinic AntagonistsMicrodialysisNeuronsSchizotypal Personality DisorderPiperidinesInterleukin 1 Receptor Antagonist ProteinGABA AntagonistsRats, WistarTyrosine 3-MonooxygenaseDopaminergic NeuronsNicotinic AntagonistsMotor ActivityVentral Tegmental AreaSubstantia NigraDopamine and cAMP-Regulated Phosphoprotein 32Purinergic P1 Receptor AntagonistsHistamine H1 AntagonistsTime FactorsSerotoninAdenosine A2 Receptor AntagonistsOxidopamineClozapineHistamine AntagonistsMesencephalonRadioligand AssayMethamphetamineDrug InteractionsAdrenergic alpha-1 Receptor AntagonistsSerotonin 5-HT2 Receptor AntagonistsAnalysis of VarianceProdromal SymptomsTropanesNorepinephrinePiperazinesPurinergic P2 Receptor AntagonistsReceptors, N-Methyl-D-AspartateCaudate Nucleus